Geraldine T Farrell insider trades: Nexvet Biopharma (NVET) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Geraldine reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 3, 2016 | NVET | ↓ Sell | 132 | $3.27 | $432 | Nexvet EBT Limited | Mar 17, 2016 (14d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Geraldine T Farrell's insider trades
Geraldine T Farrell is VP Operations, General Counsel at Nexvet Biopharma (NVET). Since Mar 3, 2016, Geraldine has reported no open-market purchases and 1 sale worth $432 on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (6 filings), grants and awards (3 filings), shares returned to the company (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVET insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.